PLOS is a non-profit organization on a mission to drive open science forward with measurable, meaningful change in research publishing, policy, and practice.

Building on a strong legacy of pioneering innovation, PLOS continues to be a catalyst, reimagining models to meet open science principles, removing barriers and promoting inclusion in knowledge creation and sharing, and publishing research outputs that enable everyone to learn from, reuse and build upon scientific knowledge.

We believe in a better future where science is open to all, for all.

Journals
More Content
PLOS BLOGS Speaking of Medicine and Health
Browse all PLOS Blogs
Browse all PLOS Blogs

This week in PLoS Medicine: Economic burden of diabetes complications; Role of T cell count in HIV treatment; Tool to identify hospital infection clusters; and more!

PLOS General

Read the new papers published in PLoS Medicine this week, including three Research Articles – the first finds that major diabetes complications are a huge economic burden to health care systems across all economic regions, the second finds that the rate of CD4 T cell decline is not useful in deciding when to start HIV treatment, and the third describes the use of a novel automated cluster detection tool, WHONET-SaTScan, made by integrating two freely available software packages, to identify hospital infection clusters.

Also published this week, a Neglected Diseases piece – the final article in a seven part series on treating mental health problems in resource-poor settings – presents  packages of care for treating Attention-Deficit/Hyperactivity Disorder in low- and middle-income countries.

And finally, the February Editorial in which the PLoS Medicine Editors announce that they will no longer consider papers for which support – in whole or in part – for the study or the researchers comes from a tobacco company.

You can comment on, annotate, and rate this week’s PLoS Medicine articles and any of the others in the archive.

Back to top